LabCorp
LH
#1069
Rank
NZ$36.37 B
Marketcap
NZ$437.70
Share price
0.00%
Change (1 day)
9.43%
Change (1 year)
Laboratory Corporation of America Holdings or LabCorp is a US company that offers clinical laboratory services. The company supplies laboratory results for the diagnosis of diseases and the development of new drugs.

EPS for LabCorp (LH)

EPS in 2025 (TTM): NZ$17.62

According to LabCorp's latest financial reports the company's current EPS (TTM) is NZ$17.80. In 2024 the company made an earnings per share (EPS) of NZ$15.44 an increase over its 2023 EPS that were of NZ$8.16.

EPS history for LabCorp from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$17.6214.15%
2024NZ$15.4489.15%
2023NZ$8.16-66.26%
2022NZ$24.19-43.33%
2021NZ$42.6954.11%
2020NZ$27.7089.43%
2019NZ$14.62-3.33%
2018NZ$15.13-29.7%
2017NZ$21.5275.74%
2016NZ$12.2463.19%
2015NZ$7.50-28.4%
2014NZ$10.48-6.13%
2013NZ$11.165.2%
2012NZ$10.61

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Quest Diagnostics
DGX
NZ$15.01-15.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.53-108.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ-$0.36-102.05%๐Ÿ‡บ๐Ÿ‡ธ USA
IDEXX Laboratories
IDXX
NZ$22.07 24.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$3.25-81.77%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands